Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?
Open Access
- 15 June 2001
- journal article
- review article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (12), 5443-5447
- https://doi.org/10.1128/jvi.75.12.5443-5447.2001
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- Efficiency of Adenovirus-Mediated Gene Transfer to Oropharyngeal Epithelial Cells Correlates with Cellular Differentiation and Human Coxsackie and Adenovirus Receptor ExpressionHuman Gene Therapy, 2000
- Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cellsOncogene, 2000
- Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: Intratumoral spread and distribution effectsCancer Gene Therapy, 1999
- Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and ΔE1B adenovirus replication in human cellsOncogene, 1999
- The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cellsOncogene, 1998
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Cell cycle targets of the DNA tumor virusesCurrent Opinion in Genetics & Development, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Replication and Interaction of Virus DNA and Cellular DNA in Mouse Cells Infected by a Human AdenovirusJournal of General Virology, 1979